Current Research Studies

ABCs: Attention Bias modification in Cancer survivors

ABCs

  • Condition(s): Anus, Bones and Joints, Brain and Nervous System, Breast, Cervix, Colon, Corpus Uteri, Esophagus, Eye and Orbit, Hodgkin's Lymphoma, Ill-Defined Sites, Kaposi's Sarcoma, Kidney, Larynx, Leukemia, other, Lip, Oral Cavity and Pharynx, Liver, Lung, Lymphoid Leukemia, Melanoma, Skin, Multiple Myeloma, Mycosis Fungoides, Myeloid and Monocytic Leukemia, Non-Hodgkin's Lymphoma, Non-malignant Disease, Other Digestive Organ, Other Endocrine System, Other Female Genital, Other Hematopoietic, Other Male Genital, Other Respiratory and Intrathoracic Organs, Other Skin, Other Urinary, Ovary, Pancreas, Prostate, Rectum, Small Intestine, Soft Tissue, Stomach, Thyroid, Unknown Sites, Urinary Bladder
  • Phase: N/A
  • Clinicaltrials.gov ID: NCT33333333

What is the goal of the study?

Cancer-related anxiety is the most prevalent mental health problem impacting one-third of AYA cancer survivors. Identification and management of anxiety are important goals for follow-up care of AYA cancer survivors. Attention bias modification (ABM) is emerging as a potential digital intervention for anxiety. This is a pilot study with three complementary aims: Aim 1. Characterize attention bias in AYA cancer survivors. Aim 2. Determine relationships between attention bias and anxiety, distress, pain, and health-related quality of life (HRQOL). Aim 3. Evaluate the feasibility and acceptability of ABM for AYA cancer survivors.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: